1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 13-19, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 13-19, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 07/14/2025
Location: Silver Spring, MD
Subject: Alzheimer’s Disease, Therapies, and Interventions Meeting
FDA Participant/Group: SARA BRENNER; GRACE GRAHAM; VINAYAK PRASAD; 
Non FDA Participant/Group: Representatives of the Alzheimer's Association (AA) and the Alzheimer's Impact Movement (AIM)

Event Date: 07/14/2025
Location: Silver Spring, MD
Subject: Prescription Drug User Fee Reauthorization Public Meeting
FDA Participant/Group: GRACE GRAHAM; 
Non FDA Participant/Group: Industry, government, media, and other stakeholders

Event Date: 07/14/2025
Location: Washington, DC
Subject: USDA Ice Cream Commitment Event
FDA Participant/Group: KYLE DIAMANTAS; BENJAMIN NICHOLS; 
Non FDA Participant/Group: Industry, government, media, and other stakeholders

Event Date: 07/15/2025
Location: Washington, DC
Subject: Introductory Meeting
FDA Participant/Group: GRACE GRAHAM; 
Non FDA Participant/Group: Representatives of Flagship Pioneering

Event Date: 07/15/2025
Location: Washington, DC
Subject: Items of Mutual Interest
FDA Participant/Group: VINAYAK PRASAD; 
Non FDA Participant/Group: Fydor Urnov (Innovative Genomics Institute); Mike Lehmicke, Tim Hunt (Alliance for Regenerative Medicine (ARM)); Rachel McMinn (Neurogene, Inc.); Devyn Smith (Arbor Biosciences);

Event Date: 07/15/2025
Location: Washington, DC
Subject: Alliance of Speciality Medicine Annual Advocacy Conference; Speaker: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Specialty physicians, practice administrations, and staff

Event Date: 07/15/2025
Location: Silver Spring, MD
Subject: Items of Mutual Interest
FDA Participant/Group: VINAYAK PRASAD; 
Non FDA Participant/Group: National Academy of Medicine leadership

Event Date: 07/16/2025
Location: Washington, DC
Subject: The Hill Nation Summit; Speaker: In Conversation With...
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 07/16/2025
Location: Silver Spring, MD
Subject: Items of Mutual Interest
FDA Participant/Group: GRACE GRAHAM; 
Non FDA Participant/Group: U.S. Government Accountability Office (GAO) Leadership Team

Event Date: 07/16/2025
Location: Silver Spring, MD 
Subject: Items of Mutual Interest
FDA Participant/Group: TIMOTHY SCHELL; JAMES TRAFICANT; 
Non FDA Participant/Group: Animal Health Institute (AHI) representatives and board members

Event Date: 07/17/2025
Location: Washington, DC
Subject: Reagan-Udall Foundation Annual Public Meeting; Panelist: FDA Leadership
FDA Participant/Group: JAMES TRAFICANT; GRACE GRAHAM; LOWELL ZETA; 
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 07/17/2025
Location: Silver Spring, MD
Subject: FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women
FDA Participant/Group: SARA BRENNER; 
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 07/15/2025
Location: College Park, MD
Subject: Food Outbreak Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; TIMOTHY JACKSON; HALLEY KROPA; AMY BARRINGER; ORVILLE HARRIS; 
Non FDA Participant/Group: Sarah Sorscher (Center for Science in the Public Interest); Sandra Eskin (Stop Foodborne Illness); Brian Ronholm (Consumer Reports);

Event Date: 07/16/2025
Location: Washington, DC
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Todd Wagner (FoodFight USA);

Event Date: 07/16/2025
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Dariush Mozaffarian (Tufts University);

Event Date: 07/16/2025
Location: Arlington, VA
Subject: Human Foods Program Priorities 
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the Consumer Brands Association

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Acting Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 07/14/2025
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives of Philips

Official Name: Jacqueline Corrigan Curay, J.D., M.D., Acting Director, Center for Drug Evaluation and Research

Event Date: 07/16/2025
Location: Washington, DC
Subject: Energy and Commerce Public Health Reauthorization for the Over-the-Counter Monograph Drug User Fee Program (OMUFA) Subcommittee Hearing
FDA Participant/Group: N/A
Non FDA Participant/Group: Energy and Commerce Health Subcommittee members

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Acting Director, Center for Veterinary Medicine

No Significant Event

Back to Top